[Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment]
- PMID: 15997169
- DOI: 10.1254/fpj.125.307
[Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment]
Similar articles
-
[Other forms of bronchodilation].Arch Bronconeumol. 2004 Mar;40 Suppl 1:23-9. doi: 10.1157/13077785. Arch Bronconeumol. 2004. PMID: 16137446 Review. Spanish. No abstract available.
-
[Tiotropium as a controller of bronchoconstriction].Pol Merkur Lekarski. 2004 May;16 Suppl 1:75-6, 78. Pol Merkur Lekarski. 2004. PMID: 15524023 Review. Polish.
-
Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.Pharmacotherapy. 2003 Feb;23(2):183-9. doi: 10.1592/phco.23.2.183.32082. Pharmacotherapy. 2003. PMID: 12587807 Review.
-
[Tiotropium bromide (Spiriva) in stablechronic obstructive pulmonary disease].Georgian Med News. 2007 Jul-Aug;(148-149):29-31. Georgian Med News. 2007. PMID: 17921539 Review. Russian.
-
The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD.Treat Respir Med. 2005;4(4):275-81. doi: 10.2165/00151829-200504040-00005. Treat Respir Med. 2005. PMID: 16086600 Review.